Fact based stock research
MediPal Holdings (TSE:7459)
JP3268950007
MediPal Holdings stock research in summary
MediPal Holdings shares are less expensive than other comparable stocks. They are good value and are safely financed, but show below average growth. We recommend evaluating whether the future of the company MediPal Holdings is really as difficult as the low price of the stock suggests. If you believe that the future of the company is market-typical or even better, then this could be an argument for a share purchase.
Latest Obermatt Ranks
Value Rank | 100 | ![]() |
Growth Rank | 18 | ![]() |
Safety Rank | 82 | ![]() |
Combined Rank | 79 | ![]() |
Country | Japan |
Industry | Health Care Distributors |
Index | |
Size class | XX-Large |
March 26, 2021. Stock data may be delayed. Login to get the most recent research.
Google: MediPal Holdings
Research History: MediPal Holdings
RESEARCH HISTORY | 2018 | 2019 | 2020 | 2021 | ||||
---|---|---|---|---|---|---|---|---|
VALUE | ||||||||
VALUE | n/a |
![]() |
n/a |
![]() |
98 |
![]() |
100 |
![]() |
GROWTH | ||||||||
GROWTH | n/a |
![]() |
n/a |
![]() |
42 |
![]() |
18 |
![]() |
SAFETY | ||||||||
SAFETY | n/a |
![]() |
n/a |
![]() |
83 |
![]() |
82 |
![]() |
COMBINED | ||||||||
COMBINED | n/a |
![]() |
n/a |
![]() |
100 |
![]() |
79 |
![]() |
Value Metrics in Detail
VALUE METRICS | 2018 | 2019 | 2020 | 2021 | ||||
---|---|---|---|---|---|---|---|---|
PRICE VS. REVENUES (P/S) | ||||||||
PRICE VS. REVENUES (P/S) | n/a |
![]() |
n/a |
![]() |
98 |
![]() |
94 |
![]() |
PRICE VS. PROFITS (P/E) | ||||||||
PRICE VS. PROFITS (P/E) | n/a |
![]() |
n/a |
![]() |
87 |
![]() |
79 |
![]() |
PRICE VS. CAPITAL (Market-to-Book) | ||||||||
PRICE VS. CAPITAL (Market-to-Book) | n/a |
![]() |
n/a |
![]() |
90 |
![]() |
88 |
![]() |
DIVIDEND YIELD | ||||||||
DIVIDEND YIELD | n/a |
![]() |
n/a |
![]() |
56 |
![]() |
80 |
![]() |
CONSOLIDATED RANK: VALUE | ||||||||
CONSOLIDATED RANK: VALUE | n/a |
![]() |
n/a |
![]() |
98 |
![]() |
100 |
![]() |
Growth Metrics in Detail
GROWTH METRICS | 2018 | 2019 | 2020 | 2021 | ||||
---|---|---|---|---|---|---|---|---|
REVENUE GROWTH | ||||||||
REVENUE GROWTH | n/a |
![]() |
n/a |
![]() |
50 |
![]() |
48 |
![]() |
PROFIT GROWTH | ||||||||
PROFIT GROWTH | n/a |
![]() |
n/a |
![]() |
56 |
![]() |
27 |
![]() |
STOCK RETURNS | ||||||||
STOCK RETURNS | n/a |
![]() |
n/a |
![]() |
32 |
![]() |
18 |
![]() |
CONSOLIDATED RANK: GROWTH | ||||||||
CONSOLIDATED RANK: GROWTH | n/a |
![]() |
n/a |
![]() |
42 |
![]() |
18 |
![]() |
Safety Metrics in Detail
SAFETY METRICS | 2018 | 2019 | 2020 | 2021 | ||||
---|---|---|---|---|---|---|---|---|
LEVERAGE | ||||||||
LEVERAGE | n/a |
![]() |
n/a |
![]() |
96 |
![]() |
94 |
![]() |
REFINANCING | ||||||||
REFINANCING | n/a |
![]() |
n/a |
![]() |
20 |
![]() |
24 |
![]() |
LIQUIDITY | ||||||||
LIQUIDITY | n/a |
![]() |
n/a |
![]() |
100 |
![]() |
100 |
![]() |
CONSOLIDATED RANK: SAFETY | ||||||||
CONSOLIDATED RANK: SAFETY | n/a |
![]() |
n/a |
![]() |
83 |
![]() |
82 |
![]() |
Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for MediPal Holdings from March 26, 2021.
We invest in our stock tips ourselves and openly publish the returns of our portfolio. That's how much we believe in our stock research. Subscribe to the top 10 stocks for 100 markets conveniently by e-mail.